The relevance of the 5HT2A–mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin

I am a Master's student in Chemistry with research experience in neurobiology, psychopharmacology, and molecular neuroscience. My work focuses on neuroplasticity, neuroprotection, and the biochemical mechanisms underlying psychiatric disorders, using animal models, molecular biology techniques, and advanced imaging methods. I have also worked with in vitro models for cancer research, exploring biochemical and molecular mechanisms relevant to disease progression and treatment.

Biomedical Engineer pursuing a Master’s degree in Biomedical Engineering, with a strong interest in neuroscience and the development of innovative solutions to address neurodegenerative pathologies. Equipped with a solid foundation in biomedical principles, research methodologies, and cutting-edge technologies, I am driven to contribute to advancing the understanding and treatment of neurological disorders.

Psychologist graduated from the National University of Colombia, MSc in Psychobiology and Ph.D. in Psychobiology (behavioral neuroscience). Doctor in Neuroscience and Behavior from the University of São Paulo in Ribeirão Preto. Associate Professor in the Department of Psychology at the University of the Andes, director of the Neuroscience and Behavior Laboratory. His area of research is neuroscience and behavioral psychopharmacology, with lines of work that include deep brain stimulation and emotional behavior and the study of animal models for Parkinson's disease and depression, among others.